Vanillylmandelic Acid (VMA)

If you have episodes of pounding heart, drenching sweats, severe headaches, or blood pressure that spikes without explanation, your doctor will eventually ask whether a rare tumor is dumping stress hormones into your bloodstream. Urinary VMA (vanillylmandelic acid) is one of the oldest tests built to answer that question.

VMA is what your body leaves behind after breaking down adrenaline and noradrenaline. Measuring it in urine gives you a window into how much of these stress hormones your body is producing over hours and days, not just the moment a tube of blood was drawn.

What VMA Actually Reflects

Adrenaline (epinephrine) and noradrenaline (norepinephrine) are produced by the inner part of your adrenal glands and by nerve endings throughout your body. After they finish their job, the liver converts them through several steps into VMA, which then leaves your body in urine. Urinary VMA is more concentrated than the original hormones, which makes it easier to detect.

Because VMA captures the integrated output of the sympathetic nervous system (the wiring that drives your fight-or-flight response), it reflects your overall stress-hormone turnover, not a single snapshot. Studies in healthy adults using radio-labeled noradrenaline have confirmed that urinary VMA tracks the broader breakdown of these hormones in the body.

Adrenaline-Producing Tumors (Pheochromocytoma)

The single most important reason adults get this test is to look for a pheochromocytoma, a rare tumor of the adrenal gland that secretes stress hormones in bursts. Classic symptoms include episodes of severe headache, sweating, palpitations, and blood pressure surges. Left undiagnosed, these tumors can trigger heart failure, hypertensive crises, and dangerous heart rhythms.

Across published studies, 24-hour urinary VMA correctly identifies somewhere between about 46 and 77 out of 100 people with the tumor (depending on whether the tumor is hereditary or sporadic and which study you look at), with specificity ranging from roughly 86 to 99 out of 100. One often-cited study reported 72 percent sensitivity and 96 percent specificity. Urinary free metanephrines, a newer test that measures hormone breakdown products closer to their source, detected all 25 tumors in that same small study, while larger series put their sensitivity closer to 92 to 97 percent. Plasma free metanephrines reach roughly 97 percent sensitivity and 93 percent specificity across pooled studies.

What this means for you: VMA is reasonably specific, meaning a clearly elevated result raises suspicion of a tumor, but its lower sensitivity means a normal VMA does not rule one out. Current Endocrine Society and NCCN guidelines actually recommend plasma free or urinary fractionated metanephrines as the first-line biochemical test, with VMA used as a supporting marker rather than the primary screen.

Childhood Neuroblastoma

VMA, together with a related compound called HVA (homovanillic acid), is a long-standing diagnostic aid for neuroblastoma, a cancer of immature nerve cells that occurs almost exclusively in children. Combined urinary VMA and HVA detect about 82 to 85 out of 100 cases. A broader urine panel that adds six more catecholamine breakdown products pushes detection to roughly 95 out of 100. Higher levels at diagnosis correlate with more advanced disease, and persistent or rising VMA during follow-up signals a higher chance of relapse.

Adult readers will rarely order VMA for this reason themselves. For children in active surveillance after neuroblastoma treatment, NCCN guidelines rely on urinary catecholamine metabolites (including VMA and HVA) alongside imaging and clinical assessment. Other tumor markers such as neuron-specific enolase (NSE) have been studied but have limited prognostic value when used alone, and one large study concluded that tumor markers are poor predictors of relapse or progression on their own.

Cardiovascular Stress and Hypertension

VMA also rises with sympathetic stress unrelated to tumors. After a heart attack, urinary VMA excretion is significantly elevated and tracks with the most dangerous complications, including low blood pressure, heart failure, and serious arrhythmias. In people with longstanding essential hypertension, urinary VMA often exceeds age-matched upper limits, though it correlates poorly with the actual blood pressure number, suggesting that elevated stress-hormone output is more often a consequence of high blood pressure than its primary cause.

Environmental Exposure and Sympathetic Tone

Newer work links higher VMA to chronic environmental stress. In a study of about 700 adults, greater exposure to volatile organic compounds (everyday airborne chemicals from paints, cleaning products, traffic, and tobacco) was associated with higher urinary VMA, consistent with chronically elevated sympathetic activity. Exposure to coarse and fine outdoor air particles produced a similar effect. These findings position VMA as an early-warning signal of the kind of low-grade sympathetic overdrive that may contribute to cardiometabolic risk over time.

Low VMA

Unusually low urinary VMA points in the opposite direction. Patients with damage to the hypothalamus from craniopharyngioma (a benign brain tumor near the pituitary) and severe obesity show reduced VMA and HVA, interpreted as decreased sympathetic outflow that contributes to lower physical activity and weight gain. Low VMA is rarely a reason to order the test on its own but can confirm reduced sympathetic drive when the clinical picture suggests it.

Why a Single Reading Can Fool You

Several everyday factors can shift a single VMA reading enough to cause confusion:

• Olives, vanilla-flavored foods, and bananas: a published case report describes olive ingestion that mimicked relapsed neuroblastoma on urinary VMA and HVA. Reduce or avoid these foods for 48 to 72 hours before collecting a sample.
• Lemon and certain citrus foods: in a small study of 14 healthy adults, daily lemon intake modestly lowered morning urine VMA, suggesting diet can pull results in either direction.
• Acute illness or recent heart attack: sympathetic stress from acute medical events significantly elevates VMA for days to weeks, and a result drawn during this window should not be interpreted as a baseline.
• Ibuprofen and tricyclic antidepressants: ibuprofen breakdown products can interfere with the lab method used to measure VMA. Tricyclic antidepressants have a more complicated effect: one older study found reduced VMA mainly in patients with bipolar depression, while broader clinical experience shows tricyclics can also raise catecholamines and metanephrines. Expert reviews recommend tapering them about two weeks before testing under medical supervision.

Collection technique matters too. A 24-hour urine collection captures total output most accurately, but spot (single-sample) urine indexed to creatinine performs nearly as well in modern labs and is far easier in real life. Whichever you choose, follow the lab's collection instructions exactly. A missed pour or partial collection in a 24-hour test can make the result meaningless.

Tracking Your Trend

A single VMA reading is far less informative than a trend. Sympathetic activity changes from day to day with stress, sleep, illness, diet, and activity. If your first result is mildly elevated and your clinical picture is not alarming, the most useful next step is usually to repeat the test under more controlled conditions (no olives or bananas, no recent illness, no new medications) rather than to launch an immediate workup.

If you are using VMA as part of a broader picture of sympathetic and metabolic health, a sensible cadence is a baseline reading, a confirmatory repeat at 3 to 6 months if results are unexpected or if you are making meaningful lifestyle changes, and at least annual monitoring after that. For surveillance after a treated catecholamine-secreting tumor, follow the cadence your specialist sets, often every few months for the first years.

Decision Pathway for Out-of-Pattern Results

Current guidelines recommend that suspected pheochromocytoma be evaluated first with plasma free metanephrines or urinary fractionated metanephrines, with VMA as a supporting marker. If your VMA is clearly elevated and metanephrines have not yet been measured, plasma free or urinary fractionated metanephrines should be ordered to confirm. If both are elevated, abdominal imaging (typically a CT or MRI of the adrenal glands) is the next step, ideally coordinated with an endocrinologist who specializes in adrenal disease.

If VMA is mildly elevated but metanephrines and a follow-up VMA are normal, the most likely explanation is diet, medication, transient stress, or environmental exposure rather than disease. If VMA is normal but your symptoms are highly suggestive of a stress-hormone-secreting tumor (recurrent episodes of headache, sweating, racing heart, and pressure spikes), do not stop the workup. A meaningful share of these tumors can be missed by VMA alone, and plasma free metanephrines should be ordered next regardless.